SUPPLEMENTARY DATA for Effect of flavanols on bone turnover markers in individuals with type 2 diabetes – a 3-month randomized placebo-controlled FLAVA trial - Dataset

Dataset

SUPPLEMENTARY DATA for Effect of flavanols on bone turnover markers in individuals with type 2 diabetes – a 3-month randomized placebo-controlled FLAVA trial

DOI

Subjects with type 2 diabetes mellitus (T2DM) have increased fracture risk with higher bone mineral density, possibly related to increased advanced glycation end-products (AGEs) accumulation. Studies showed reduced AGEs formation and improved bone markers when treated with flavanols but not in subjects with T2DM.Aim;To study the effect of flavanols supplementation on bone turnover markers (BTMs) in participants with T2DM.

Date Submitted: 2022-02-23

Identifier
DOI	https://doi.org/10.17026/dans-zf2-vavp
Metadata Access	https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/dans-zf2-vavp

Provenance
Creator	Erasmus MC Rotterdam The Netherlands
Publisher	DANS Data Station Life Sciences
Contributor	F.J.A. van Rooij
Publication Year	2022
Rights	CC-BY-NC-ND-4.0; info:eu-repo/semantics/openAccess; http://creativecommons.org/licenses/by-nc-nd/4.0
OpenAccess	true
Contact	F.J.A. van Rooij (Erasmus MC)

Representation
Resource Type	Dataset
Format	application/zip; application/pdf
Size	10778; 462647
Version	1.0
Discipline	Life Sciences; Medicine